Diabetes Type 2 Flashcards
(43 cards)
What is the first-line treatment for type 2 diabetes?
Metformin (assess tolerability first).
What if metformin is contraindicated or not tolerated?
Consider SGLT2 inhibitor monotherapy.
What form of metformin may help with GI issues?
Metformin MR (modified release).
Name the main oral drug classes for type 2 diabetes.
Metformin, SGLT2 inhibitors, DPP-4 inhibitors, Pioglitazone, Sulfonylureas.
What are examples of SGLT2 inhibitors (‘flozins’)?
Canagliflozin, Dapagliflozin, Empagliflozin, Ertugliflozin.
Benefits of SGLT2 inhibitors?
Weight loss, low hypoglycaemia risk, cardiovascular and renal protection.
Examples of DPP-4 inhibitors?
Alogliptin, Linagliptin, Saxagliptin, Sitagliptin, Vildagliptin.
Key considerations of DPP-4 inhibitors?
Weight neutral, low hypoglycaemia risk, adjust dose in renal/hepatic impairment (except some).
What are GLP-1 mimetics indicated for?
If triple therapy fails and the patient is obese (BMI ≥35 or <35 with specific concerns).
When is insulin considered?
When dual therapy fails to achieve glycaemic targets.
Which medication is associated with weight gain and high hypoglycaemia risk in older people?
Sulfonylureas - glipizide, glimepiride, and gliclazide.
Which medication should be avoided in heart failure or bladder cancer?
Pioglitazone.
What is recommended for symptomatic hyperglycaemia?
Consider insulin or a sulfonylurea, and review once blood glucose is controlled.
Examples of GLP-1 receptor agonists?
Dulaglutide, Exenatide, Liraglutide, Lixisenatide, Semaglutide.
Which class is generally avoided or used cautiously in renal impairment?
SGLT2 inhibitors, Metformin, Sulfonylureas, and some DPP-4s.
Which class is safest in renal impairment?
DDP-4 inhibitors - especially linagliptin as no dose adjustment needed.
Which meds require caution or avoidance in hepatic impairment?
Most — especially SGLT2 inhibitors, Sulfonylureas, and Pioglitazone.
What defines Type 2 Diabetes Mellitus (T2DM)?
A metabolic disorder with persistent hyperglycaemia due to insulin resistance and deficient insulin secretion.
Diagnostic criteria for T2DM (adults)?
HbA1c ≥ 48 mmol/mol (6.5%)
OR random plasma glucose >11.1 mmol/L
OR fasting glucose ≥ 7.0 mmol/L
Name key risk factors for T2DM.
Obesity, inactivity, high-risk ethnicity (Asian, African, Afro-Caribbean), family history, gestational diabetes, corticosteroid use, poor diet.
Classic symptoms of T2DM?
Polyuria, polydipsia, weight loss, fatigue.
What skin sign may indicate insulin resistance?
Acanthosis nigricans - a condition that causes areas of dark, thick velvety skin in body folds and creases.
Macrovascular complications of T2DM?
CVD (heart disease, stroke, PAD).
Microvascular complications of T2DM?
Nephropathy, retinopathy, neuropathy.